Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due
to the rise in morbidity and mortality, it has become a global health problem. To date, T2DM …

Branched-chain amino acid (BCAA) catabolism has been considered to have an emerging
role in the pathogenesis of metabolic disturbances in obesity and type 2 diabetes (T2D) …

Branched-chain amino acids (BCAAs) are critical for skeletal muscle and whole-body
anabolism and energy homeostasis. They also serve as signaling molecules, for example …

Elevations in plasma branched-chain amino acid (BCAA) levels associate with insulin
resistance and type 2 diabetes (T2D). Pre-clinical models suggest that lowering BCAA levels …

Branched-chain amino acids (BCAAs) include leucine, isoleucine, and valine. Mammalians
cannot synthesize these amino acids de novo and must acquire them through their diet …

For more than a decade, there has been a wide debate about the branched-chain amino
acids (BCAA) leucine, valine, and isoleucine, with, on the one hand, the supporters of their …

Elevations in circling branched‐chain amino acids (BCAAs) levels associated with insulin
resistance and type 2 diabetes mellitus (T2DM). Morus alba L. water extracts (MLE) show …

Insulin resistance is an important feature of metabolic syndrome and a precursor of type 2
diabetes mellitus (T2DM). Overnutrition-induced obesity is a major risk factor for the …

Branched-chain amino acids (BCAAs; a mixture of leucine, valine and isoleucine) have
important regulatory effects on glucose and lipid metabolism, protein synthesis and …

Abstract β2-agonist treatment improves skeletal muscle glucose uptake and whole-body
glucose homeostasis in rodents, likely via mTORC2-mediated signalling. However, human …